Jared Cumming

Company: Matchpoint Therapeutics

Job title: Chief Scientific Officer

Seminars:

Identification of Functional Covalent Hits with Novel Mechanisms of Action for Hard-to-Drug Targets 9:30 am

Drugging elusive targets with high affinity, selectivity and tolerability Strategies for target selection and warhead tuning to facilitate selective, potent bindingRead more

day: Day One